Merlin Biomedical Consulting LLC

The difficult we do immediately.

The impossible takes a little longer.

About Us

Phone: 973-685-6068

Skype: Jay.Wiggins

E-mail: info@merlinbioconsult.con

Jay R. Wiggins, Ph.D.

Principal

 

Dr. Wiggins’ career spans both academic medicine and industry. He has more than 30 years experience in the pharmaceutical industry, encompassing both drug discovery and clinical development in the United States and Europe. In the course of his career, he has managed pre-clinical drug discovery efforts from identification of lead compounds with associated patents through Investigational New Drug (IND) filings with the US Food and Drug Administration.

 

In his clinical role, Dr. Wiggins has directed global clinical programs through New Drug Applications (NDAs) and post-marketing efforts, including management of multifunctional teams, clinical research organizations, and international trials. Dr. Wiggins has also served as a medical liaison and core clinician for marketing and clinical operations, providing guidance for worldwide pharmaceutical development. He has more than 40 publications, largely in the fields of cardiovascular biology and medicine.

 

He has conceived and executed more than 30 clinical protocols in both the US and Europe and consulted on protocol design in Japan. His active participation in the analysis and reporting of many of these studies has taught him that there are no “routine” studies, and therefore there are no routine results.

 

 

 

Patrice Bell

Sr Clinical Consultant

 

Patrice Bell has been involved with clinical research since 1985 in a variety of management positions from Clinical Scientist/Liaison to Senior Director of Clinical Operations and Project Management. She has functioned from both the pharmaceutical and CRO perspectives.

 

Patrice has managed international mega-trials, functioning as a core member of clinical teams interacting in up to 28 countries. Her research has spanned several therapeutic areas, but Patrice’s primary focus is cardiovascular and CNS pathologies. She has participated in multiple new drug application (NDA) submissions and has been a speaker at national and international conferences in these therapeutic areas. She is also involved in international discussion groups for good clinical practices and clinical research.

 

Patrice’s tasks have spanned business development proposals and clinical program implementation and management to medical writing of documents for submission of new drug applications.

 

 

The company’s slogan is adapted from those used by the U.S. Army Corps of Engineers and the U.S. Navy Seabees in World War II. It reflects Dr. Wiggins’s aggressive approach to project planning.

 

“Set your course by the stars, not by the lights of every passing ship.” Omar N. Bradley

To contact us:

Copyright © 2006—2012 Merlin Biomedical Consulting LLC. All rights reserved.